Prophylactic Minimally Invasive Surfactant Evaluation

• Status: Recruiting
• Trial end date: 2027-07-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: NorthShore University HealthSystem
• Collaborator: Chiesi USA, Inc.
• Treatments: Poractant alfa

Criteria

Inclusion Criteria:

• Gestational age <30 weeks

• Antenatal consent from Parent

Exclusion Criteria:

• Congenital anomalies

• Alternate cause of respiratory distress